SCHEMBL3762403

SCHEMBL3762403

COc1cccc([C@@H]2O[C@@H]2[Si](C)(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 2/20 0.44
HTR2A P28223 2/20 0.44
HTR2B P41595 2/20 0.44
GAA P10253 1/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C19 P33261 2/20 0.43
HIF1A Q16665 2/20 0.43
POLB P06746 1/20 0.43
NFKB1 P19838 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11162641 0.79 HTR2C (0.50) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL23676966 0.74 HTR2C (0.61) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL4077148 0.72 SLC5A2 (0.52) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL10078467 0.72 EPHX1 (0.38) HTR2BCYP2C19
SCHEMBL7784267 0.70 HTR2C (0.54) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL746723 0.70 HTR2C (0.49) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL6493903 0.70 HTR2C (0.54) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL936624 0.70 HTR2C (0.54) HTR2CMEN1KMT2AKDM4ENPC1
SCHEMBL10078444 0.70 SLC6A4 (0.42) HTR2CKDM4EHTR2BCYP3A4CYP2D6
SCHEMBL9692360 0.70 TSHR (0.51) HTR2CMEN1KMT2AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217184-B2 Process for producing optically active cis-silyl olefin oxide compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-07-10 US disclosed
US-8217184-B2 Process for producing optically active cis-silyl olefin oxide compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-07-10 US disclosed
US-20100305338-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-12-02 US disclosed
US-20100305338-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305338-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND CYP51A1, MSMO1, SQLE HTR2C 4212/4885MEN1 2050/4885KMT2A 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.